triiodothyronine has been researched along with Breast Cancer in 106 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Breast cancer (BC) severely threatens women's life, and Triiodothyronine (T3) shows a positive role on BC cell proliferation, while the potential mechanism underlying it is still unclear." | 7.91 | Triiodothyronine Promotes Cell Proliferation of Breast Cancer via Modulating miR-204/Amphiregulin. ( Guo, Y; Li, Y; Qi, X; Zhang, F; Zhang, L, 2019) |
| "To better understand the estrogen (E2) agonist action of triiodothyronine (T3) the effects of these hormones on ER negative MDA-MB-231 breast cancer cells were compared with those on S30, a clone of MDA-MB-231 stably transfected with ERalpha cDNA, in terms of proliferation and modulation of hormone receptors." | 7.75 | Influence of estradiol and triiodothyronine on breast cancer cell lines proliferation and expression of estrogen and thyroid hormone receptors. ( Brentani, MM; Cestari, SH; Clara, S; Conde, SJ; Figueiredo, NB; Katayama, ML; Nogueira, CR; Padovani, CR, 2009) |
| "To examine the effects of triiodothyronine (T3), 17beta-estradiol (E2), and tamoxifen (TAM) on transforming growth factor (TGF)-alpha gene expression in primary breast cancer cell cultures and interactions between the different treatments." | 7.74 | Tamoxifen inhibits transforming growth factor-alpha gene expression in human breast carcinoma samples treated with triiodothyronine. ( Brentani, MM; Conde, SJ; Katayama, ML; Luvizotto, RA; Nogueira, CR; Síbio, MT, 2008) |
| "Thyroid function was evaluation in 26 postmenopausal women with breast cancer before and at various time intervals during treatment with tamoxifen." | 7.70 | Thyroid function in postmenopausal breast cancer patients treated with tamoxifen. ( Aakvaag, A; Anker, GB; Lien, EA; Lønning, PE, 1998) |
| "Within a case-control study of postmenopausal breast cancer patients (n = 99) and matched healthy controls (n = 105), thyroid hormone levels were compared and correlated with toenail selenium concentrations." | 7.69 | Thyroid hormones and selenium status in breast cancer. ( Bokje, E; Coulter, J; Logan, H; Odling-Smee, W; Spence, RA; Steele, K; Stewart, C; Strain, JJ; van't Veer, P, 1997) |
| "Aminoglutethimide is effective in the treatment of breast cancer in postmenopausal patients as a result of its inhibition of aromatase." | 7.68 | Low-dose aminoglutethimide in postmenopausal breast cancer: effects on adrenal and thyroid hormone secretion. ( Cantwell, BM; Dowsett, M; Harris, AL; Mehta, A, 1991) |
| "Plasma triiodothyronine (T3), thyroxine (T4) and thyroid-stimulating hormone (TSH) were measured in 44 early breast cancer patients, 48 with advanced breast cancer, 20 with cancer of the colon, and 56 healthy women of similar age." | 7.66 | Plasma triiodothyronine concentrations in breast cancer. ( Davis, TE; Rose, DP, 1979) |
| "The conflict between breast cancer (BC) and thyroid hormone (TH) has been studied for years." | 6.82 | Free triiodothyronine and free thyroxine hormone levels in relation to breast cancer risk: a meta-analysis. ( Deng, Q; Guo, D; Lei, Z; Wu, L; Zeng, B, 2022) |
| " T3 levels in postmenopausal women were positively associated with the risk of breast cancer in a dose-response manner." | 5.36 | Prospectively measured triiodothyronine levels are positively associated with breast cancer risk in postmenopausal women. ( Bondeson, AG; Bondeson, L; Ericsson, UB; Malm, J; Manjer, J; Tosovic, A, 2010) |
| "The women with other-than-breast cancer and the women with miscellaneous non-cancerous illnesses also showed significant elevations of spot T4 levels, indistinguishable from those of the breast cancer patients." | 5.26 | Plasma levels of thyroxine and triiodothyronine in women with breast cancer. ( Fukushima, DK; Levin, J; Markham, M; O'Connor, J; Strain, GW; Zumoff, B, 1981) |
| "Seventy patients with advanced metastatic breast cancer were treated with an oral drug regime of prednisone, cytomel, cytoxan, and methotrexate." | 5.05 | Treatment of breast cancer with oral four-drug chemotherapy. ( Foley, JF; Kessinger, MA; Lemon, HM, 1980) |
| "The active thyroid hormone triiodothyronine (T3) has been found to have an estrogen-like effect on breast cancer cells." | 4.02 | Low thyroid hormone receptor alpha-2 (THRα-2) tumor expression is associated with unfavorable tumor characteristics and high breast cancer mortality. ( Borgquist, S; Manjer, J; Rosendahl, AH; Sandsveden, M, 2021) |
| "Breast cancer (BC) severely threatens women's life, and Triiodothyronine (T3) shows a positive role on BC cell proliferation, while the potential mechanism underlying it is still unclear." | 3.91 | Triiodothyronine Promotes Cell Proliferation of Breast Cancer via Modulating miR-204/Amphiregulin. ( Guo, Y; Li, Y; Qi, X; Zhang, F; Zhang, L, 2019) |
| " In this work, we demonstrate that the thyroid hormone triiodothyronine (T3) regulates actin remodeling and cell movement in breast cancer T-47D cells through the recruitment of FAK." | 3.85 | Thyroid Hormone Controls Breast Cancer Cell Movement via Integrin αV/β3/SRC/FAK/PI3-Kinases. ( Cuello-Carrión, FD; Flamini, MI; Jahn, GA; Mondaca, JM; Neira, FJ; Pennacchio, GE; Sanchez, AM; Simoncini, T; Uzair, ID, 2017) |
| "High fT4 was associated with a statistically significant higher risk of overall breast cancer, small, grade I, ER-positive, PgR-positive, and cyclin D1 low tumors." | 3.81 | Prospectively measured thyroid hormones and thyroid peroxidase antibodies in relation to risk of different breast cancer subgroups: a Malmö Diet and Cancer Study. ( Borgquist, S; Brandt, J; Manjer, J, 2015) |
| "In the present study, we analyze and characterize the levels of PCBs and OH-PCBs in serum and breast adipose tissue, and measure TH (total 3,5,5'-triiodothyronine (tT3) and total l-thyroxine (tT4)) levels in serum of Japanese women diagnosed with breast cancer (n = 51) to know how PCBs affect thyroid hormone homeostasis." | 3.76 | Determination and characterization of hydroxylated polychlorinated biphenyls (OH-PCBs) in serum and adipose tissue of Japanese women diagnosed with breast cancer. ( Akiba, S; Koga, M; Koriyama, C; Nomiyama, K; Shinohara, R; Yamamoto, M; Yonehara, T; Yonemura, S, 2010) |
| "To better understand the estrogen (E2) agonist action of triiodothyronine (T3) the effects of these hormones on ER negative MDA-MB-231 breast cancer cells were compared with those on S30, a clone of MDA-MB-231 stably transfected with ERalpha cDNA, in terms of proliferation and modulation of hormone receptors." | 3.75 | Influence of estradiol and triiodothyronine on breast cancer cell lines proliferation and expression of estrogen and thyroid hormone receptors. ( Brentani, MM; Cestari, SH; Clara, S; Conde, SJ; Figueiredo, NB; Katayama, ML; Nogueira, CR; Padovani, CR, 2009) |
| "To examine the effects of triiodothyronine (T3), 17beta-estradiol (E2), and tamoxifen (TAM) on transforming growth factor (TGF)-alpha gene expression in primary breast cancer cell cultures and interactions between the different treatments." | 3.74 | Tamoxifen inhibits transforming growth factor-alpha gene expression in human breast carcinoma samples treated with triiodothyronine. ( Brentani, MM; Conde, SJ; Katayama, ML; Luvizotto, RA; Nogueira, CR; Síbio, MT, 2008) |
| "Thyroid function was evaluation in 26 postmenopausal women with breast cancer before and at various time intervals during treatment with tamoxifen." | 3.70 | Thyroid function in postmenopausal breast cancer patients treated with tamoxifen. ( Aakvaag, A; Anker, GB; Lien, EA; Lønning, PE, 1998) |
| "Within a case-control study of postmenopausal breast cancer patients (n = 99) and matched healthy controls (n = 105), thyroid hormone levels were compared and correlated with toenail selenium concentrations." | 3.69 | Thyroid hormones and selenium status in breast cancer. ( Bokje, E; Coulter, J; Logan, H; Odling-Smee, W; Spence, RA; Steele, K; Stewart, C; Strain, JJ; van't Veer, P, 1997) |
| "Aminoglutethimide is effective in the treatment of breast cancer in postmenopausal patients as a result of its inhibition of aromatase." | 3.68 | Low-dose aminoglutethimide in postmenopausal breast cancer: effects on adrenal and thyroid hormone secretion. ( Cantwell, BM; Dowsett, M; Harris, AL; Mehta, A, 1991) |
| "In breast cancer a decrease in triiodothyronine concentration was revealed with the normal level of thyroxine that may be associated with the disturbed peripheral metabolism into triiodothyronine." | 3.67 | [Thyroid and hypophyseal function during radiation therapy of breast cancer]. ( Iakimova, TP; Lozinskaia, IN, 1984) |
| "The paper is concerned with the results of investigation of the body composition and albumin circulation using a method of whole-body radiometry, extracellular liquid volume--by a 40K-RP, the level of cortisol, T3, insulin, C-peptide in the blood plasma by a radioimmunoassay in 30 breast cancer patients." | 3.67 | [Radionuclide evaluation of postoperative catabolism in breast cancer]. ( Kaplan, MA; Khmelevskiĭ, IaM; Shakhtarin, VV; Sloventator, VIu; Titov, VK, 1988) |
| "Serum tri-iodothyronine (T3), thyroxine (T4) and thyroid-stimulating hormone (TSH) concentrations were measured in 50 postmenopausal patients with breast cancer receiving tamoxifen therapy." | 3.67 | The effect of tamoxifen therapy on thyroid function tests. ( Beastall, GH; Gordon, D; McArdle, CS; Thomson, JA, 1986) |
| "Levels of circulating estrone (E1), estradiol (E2), androst-4-ene-3,17-dione (Adione), 3,5,3'-triiodothyronine (T3), thyroxine (T4), and sex hormone-binding globulin (SHBG) were measured in 10 obese postmenopausal patients with breast cancer and in 10 obese postmenopausal control subjects matched for age, body size, and menopausal status." | 3.67 | Decrease of circulating level of SHBG in postmenopausal obese women as a risk factor in breast cancer: reversible effect of weight loss. ( Cardillo, LR; del Carmen Cremona, M; Enriori, CL; Etkin, AE; Orsini, W; Reforzo-Membrives, J, 1986) |
| "Serum 'free thyroxine' was measured as a thyroid function index (TFI) in 238 women with early breast cancer and 107 normal controls." | 3.66 | Thyroid function in early breast cancer. ( Bulbrook, RD; Hayward, JL; Millis, R; Russell, MJ; Thomas, BS, 1983) |
| "Plasma triiodothyronine (T3), thyroxine (T4) and thyroid-stimulating hormone (TSH) were measured in 44 early breast cancer patients, 48 with advanced breast cancer, 20 with cancer of the colon, and 56 healthy women of similar age." | 3.66 | Plasma triiodothyronine concentrations in breast cancer. ( Davis, TE; Rose, DP, 1979) |
| "In 41 women newly diagnosed as having breast cancer the thyroid function was assessed by determination of the serum TSH, tririodothyronine (T3), reverse triiodothyronine (rT3), thyroxine (T4), T3-resin uptake and free T4-index." | 3.66 | Thyroid function in breast cancer patients before and up to two years after mastectomy. ( Adami, HO; Hansen, J; Rimsten, A; Wide, L, 1979) |
| "Patients with breast cancer were studied with regard to changes in the levels of serum thyroxine (T4) and serum triidothyronine (T3) after intramuscular administration of TSH for three days to investigate the thyroid reserve in these patients." | 3.65 | The thyroid reserve in patients with breast cancer. ( Abe, R; Kimura, M; Saito, S; Sakurada, T; Yoshida, K, 1977) |
| "The conflict between breast cancer (BC) and thyroid hormone (TH) has been studied for years." | 2.82 | Free triiodothyronine and free thyroxine hormone levels in relation to breast cancer risk: a meta-analysis. ( Deng, Q; Guo, D; Lei, Z; Wu, L; Zeng, B, 2022) |
| "Some 766 patients with incident breast cancer were identified, of whom 551 were eligible for analysis." | 1.43 | Thyroid function and survival following breast cancer. ( Almquist, M; Borgquist, S; Brandt, J; Manjer, J, 2016) |
| "Since BRCA1 associated breast cancers are frequently classified as hormone receptor negative or even triple negative, the application of endocrine therapies is rather limited in these patients." | 1.42 | Thyroid Hormone Receptors Predict Prognosis in BRCA1 Associated Breast Cancer in Opposing Ways. ( Angele, M; Ditsch, N; Gallwas, J; Heublein, S; Jeschke, U; Mayr, D; Meindl, A, 2015) |
| "A total of 120 female breast cancer patients and women 100 healthy subjects were enrolled in this study." | 1.39 | Status of oral ulcerative mucositis and biomarkers to monitor posttraumatic stress disorder effects in breast cancer patients. ( Cheung, MN; Chow, LW; Liu, Q; Loo, WT; Ng, EL; Wang, M; Yip, AY; Yip, MC, 2013) |
| " T3 levels in postmenopausal women were positively associated with the risk of breast cancer in a dose-response manner." | 1.36 | Prospectively measured triiodothyronine levels are positively associated with breast cancer risk in postmenopausal women. ( Bondeson, AG; Bondeson, L; Ericsson, UB; Malm, J; Manjer, J; Tosovic, A, 2010) |
| "The involvement of estrogens in breast cancer development and growth has been well established." | 1.35 | Effects of thyroid hormones on human breast cancer cell proliferation. ( Hall, LC; Kane, SR; Liu, N; Salazar, EP, 2008) |
| "By contrast, 20 out of the 36 breast cancer tissues, mainly grades G1 and G2, expressed abundant type 1 5'-deiodinase activity and/or a high mRNA level." | 1.34 | Human breast cancer tissue expresses high level of type 1 5'-deiodinase. ( Ambroziak, M; Bar-Andziak, E; Debski, MG; Olszewski, W; Pachucki, J, 2007) |
| "Human breast cancer primary cultures are useful tools for the study of several aspects of cancer biology, including the effects of chemotherapy and acute gene expression in response to different hormonal/chemotherapy treatments." | 1.32 | Three novel hormone-responsive cell lines derived from primary human breast carcinomas: functional characterization. ( Baldi, A; Garbovesky, C; Lüthy, IA; Mladovan, A; Vázquez, SM, 2004) |
| "Until now, NIS activity in breast cancer metastases (BCM) was unproven." | 1.32 | The Na+/I- symporter mediates iodide uptake in breast cancer metastases and can be selectively down-regulated in the thyroid. ( Adelman, D; Carrasco, N; Dohan, O; Goris, M; Nowels, K; Wapnir, IL; Yudd, A, 2004) |
| "Studies on breast cancer have been inconclusive, suggesting contradictory effects of thyroid status and diseases." | 1.30 | Inhibition of tenascin-C expression in mammary epithelial cells by thyroid hormone. ( Alvarez-Dolado, M; Caelles, C; González-Sancho, JM; Muñoz, A, 1999) |
| "The invasiveness of MCF-7 human mammary carcinoma cells was tested in vitro via confronting cultures with embryonic chick heart fragments." | 1.28 | Retinoic acid modulates both invasion and plasma membrane ruffling of MCF-7 human mammary carcinoma cells in vitro. ( Bracke, ME; Mareel, MM; Van Larebeke, NA; Vyncke, BM, 1991) |
| "It was only found in hepatoma cells where it is regulated by estradiol, antiestrogen tamoxifen and triiodothyronine, in a similar way as secreted SBP." | 1.28 | Regulation of SBP synthesis in human cancer cell lines by steroid and thyroid hormones. ( Baulieu, EE; Baville, F; Bideux, G; Binart, N; Chambraud, B; Mercier-Bodard, C, 1989) |
| "Eight women with breast cancer (3." | 1.27 | Thyroid function in women with breast cancer. ( Baugnet-Mahieu, L; Lemaire, M, 1986) |
| "These results indicate that breast cancer and thyroid disease are probably related, but not in a specific way, since benign mastopathy also seems to be associated with thyroid disturbances." | 1.27 | Thyroid disease in patients with benign and malignant mastopathy. ( Adamopoulos, DA; Georgiakodis, F; Kapolla, N; Michalakis, A; Papadiamantis, J; Vassilaros, S, 1986) |
| "Subclinical and clinical primary hypothyroidism was significantly more frequent in breast cancer patients who had previously received irradiation on supraclavicular lymph nodes comprising a minor part of the thyroid." | 1.27 | Primary hypothyroidism in breast cancer patients with irradiated supraclavicular lymph nodes. ( Bonfrèr, J; Bruning, P; Burgers, M; De Jong-Bakker, M; Nooyen, W, 1985) |
| "Plasma T3 levels were reduced in both breast cancer group, but were reduced only in colonic cancer patients with systemic metastases." | 1.26 | Plasma thyronine levels in carcinoma of the breast and colon. ( Davis, TE; Rose, DP, 1981) |
| "The women with other-than-breast cancer and the women with miscellaneous non-cancerous illnesses also showed significant elevations of spot T4 levels, indistinguishable from those of the breast cancer patients." | 1.26 | Plasma levels of thyroxine and triiodothyronine in women with breast cancer. ( Fukushima, DK; Levin, J; Markham, M; O'Connor, J; Strain, GW; Zumoff, B, 1981) |
| "Of 145 women with metastatic breast carcinoma who survived palliative surgical castration, 40." | 1.26 | Therapeutic oophorectomy in disseminated carcinoma of the breast. ( Bisel, HF; Puga, FJ; Welch, JS, 1976) |
| "ZR-75-1, a human breast cancer cell line, has been grown in hormone-supplemented medium without serum." | 1.26 | Growth of a human breast cancer cell line in serum-free hormone-supplemented medium. ( Allegra, JC; Lippman, ME, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 55 (51.89) | 18.7374 |
| 1990's | 16 (15.09) | 18.2507 |
| 2000's | 8 (7.55) | 29.6817 |
| 2010's | 22 (20.75) | 24.3611 |
| 2020's | 5 (4.72) | 2.80 |
| Authors | Studies |
|---|---|
| Germain, AR | 1 |
| Carmody, LC | 1 |
| Nag, PP | 1 |
| Morgan, B | 1 |
| Verplank, L | 1 |
| Fernandez, C | 1 |
| Donckele, E | 1 |
| Feng, Y | 1 |
| Perez, JR | 1 |
| Dandapani, S | 1 |
| Palmer, M | 1 |
| Lander, ES | 1 |
| Gupta, PB | 1 |
| Schreiber, SL | 1 |
| Munoz, B | 1 |
| Sandsveden, M | 1 |
| Borgquist, S | 3 |
| Rosendahl, AH | 1 |
| Manjer, J | 7 |
| Meirovitz, A | 1 |
| Nisman, B | 2 |
| Allweis, TM | 2 |
| Carmon, E | 2 |
| Kadouri, L | 2 |
| Maly, B | 2 |
| Maimon, O | 2 |
| Peretz, T | 2 |
| Lei, Z | 1 |
| Zeng, B | 1 |
| Wu, L | 1 |
| Deng, Q | 1 |
| Guo, D | 1 |
| Planck, T | 1 |
| Hedberg, F | 1 |
| Calissendorff, J | 1 |
| Nilsson, A | 1 |
| Meierovich, A | 1 |
| Yamauchi, I | 1 |
| Sakane, Y | 1 |
| Fukuda, Y | 1 |
| Fujii, T | 1 |
| Taura, D | 1 |
| Hirata, M | 1 |
| Hirota, K | 1 |
| Ueda, Y | 1 |
| Kanai, Y | 1 |
| Yamashita, Y | 1 |
| Kondo, E | 1 |
| Sone, M | 1 |
| Yasoda, A | 1 |
| Inagaki, N | 1 |
| Hercbergs, A | 1 |
| Mousa, SA | 1 |
| Leinung, M | 1 |
| Lin, HY | 1 |
| Davis, PJ | 1 |
| Ortega-Olvera, C | 1 |
| Ulloa-Aguirre, A | 1 |
| Ángeles-Llerenas, A | 1 |
| Mainero-Ratchelous, FE | 1 |
| González-Acevedo, CE | 1 |
| Hernández-Blanco, ML | 1 |
| Ziv, E | 1 |
| Avilés-Santa, L | 1 |
| Pérez-Rodríguez, E | 1 |
| Torres-Mejía, G | 1 |
| Zhang, L | 1 |
| Zhang, F | 1 |
| Li, Y | 1 |
| Qi, X | 1 |
| Guo, Y | 1 |
| Kim, EY | 1 |
| Chang, Y | 1 |
| Lee, KH | 1 |
| Yun, JS | 1 |
| Park, YL | 1 |
| Park, CH | 1 |
| Ahn, J | 1 |
| Shin, H | 1 |
| Ryu, S | 1 |
| Baldini, M | 1 |
| Gambini, D | 1 |
| Airaghi, L | 1 |
| Tomirotti, M | 1 |
| Cappellini, MD | 1 |
| Loo, WT | 1 |
| Liu, Q | 1 |
| Yip, MC | 1 |
| Wang, M | 1 |
| Chow, LW | 1 |
| Cheung, MN | 1 |
| Yip, AY | 1 |
| Ng, EL | 1 |
| Huang, J | 1 |
| Jin, L | 1 |
| Ji, G | 1 |
| Xing, L | 1 |
| Xu, C | 1 |
| Xiong, X | 1 |
| Li, H | 1 |
| Wu, K | 1 |
| Ren, G | 1 |
| Kong, L | 1 |
| Figueiredo, NB | 2 |
| Cestari, SH | 2 |
| Conde, SJ | 3 |
| Luvizotto, RA | 2 |
| De Sibio, MT | 1 |
| Perone, D | 1 |
| Katayama, ML | 3 |
| Carraro, DM | 1 |
| Brentani, HP | 1 |
| Brentani, MM | 4 |
| Nogueira, CR | 4 |
| Tosovic, A | 4 |
| Bondeson, AG | 4 |
| Bondeson, L | 4 |
| Ericsson, UB | 4 |
| Shi, XZ | 1 |
| Jin, X | 1 |
| Xu, P | 1 |
| Shen, HM | 1 |
| Heublein, S | 1 |
| Mayr, D | 1 |
| Meindl, A | 1 |
| Angele, M | 1 |
| Gallwas, J | 1 |
| Jeschke, U | 1 |
| Ditsch, N | 1 |
| Brandt, J | 2 |
| Khan, MA | 1 |
| Bhurani, D | 1 |
| Agarwal, NB | 1 |
| Almquist, M | 1 |
| Flamini, MI | 1 |
| Uzair, ID | 1 |
| Pennacchio, GE | 1 |
| Neira, FJ | 1 |
| Mondaca, JM | 1 |
| Cuello-Carrión, FD | 1 |
| Jahn, GA | 1 |
| Simoncini, T | 1 |
| Sanchez, AM | 1 |
| Síbio, MT | 1 |
| Clara, S | 1 |
| Padovani, CR | 1 |
| Nomiyama, K | 1 |
| Yonehara, T | 1 |
| Yonemura, S | 1 |
| Yamamoto, M | 1 |
| Koriyama, C | 1 |
| Akiba, S | 1 |
| Shinohara, R | 1 |
| Koga, M | 1 |
| Malm, J | 2 |
| Suhane, S | 1 |
| Ramanujan, VK | 1 |
| Becker, C | 1 |
| García-Solís, P | 1 |
| Aceves, C | 1 |
| COREY, KR | 2 |
| GROSS, J | 2 |
| SPENGLER, JR | 1 |
| CRUMMY, AB | 1 |
| VERMUND, H | 1 |
| GARDNER, B | 5 |
| GORDAN, GS | 4 |
| LOKEN, HF | 2 |
| THOMAS, AN | 3 |
| STOLL, BA | 1 |
| WITT, JA | 1 |
| GRAHAM, WP | 3 |
| SCHUBERT, K | 3 |
| BACIGALUPO, G | 3 |
| TEAL, JS | 1 |
| BAKKE, JL | 1 |
| KAMMER, H | 1 |
| LAWRENCE, N | 1 |
| DARGENT, M | 1 |
| BERGER, M | 1 |
| LAHNECHE, B | 1 |
| Vázquez, SM | 1 |
| Mladovan, A | 1 |
| Garbovesky, C | 1 |
| Baldi, A | 1 |
| Lüthy, IA | 1 |
| Wapnir, IL | 1 |
| Goris, M | 1 |
| Yudd, A | 1 |
| Dohan, O | 1 |
| Adelman, D | 1 |
| Nowels, K | 1 |
| Carrasco, N | 1 |
| Debski, MG | 1 |
| Pachucki, J | 1 |
| Ambroziak, M | 1 |
| Olszewski, W | 1 |
| Bar-Andziak, E | 1 |
| Hall, LC | 1 |
| Salazar, EP | 1 |
| Kane, SR | 1 |
| Liu, N | 1 |
| Cerbon, MA | 1 |
| Pichon, MF | 1 |
| Milgrom, E | 1 |
| Calvo, F | 1 |
| Carney, DN | 1 |
| Brower, M | 1 |
| Minna, JD | 1 |
| Iakimova, TP | 1 |
| Lozinskaia, IN | 1 |
| Sidorenko, LN | 1 |
| Popova, SP | 1 |
| Borina, ZN | 1 |
| Egor'kova, AS | 1 |
| Korovin, KF | 1 |
| Thomas, BS | 1 |
| Bulbrook, RD | 1 |
| Russell, MJ | 1 |
| Hayward, JL | 1 |
| Millis, R | 1 |
| Draves, DP | 1 |
| Ruzicka, FJ | 1 |
| Rose, DP | 3 |
| Abe, R | 2 |
| Hirosaki, A | 1 |
| Kimura, M | 2 |
| Davis, TE | 2 |
| Foley, JF | 1 |
| Kessinger, MA | 1 |
| Lemon, HM | 1 |
| Zumoff, B | 1 |
| O'Connor, J | 1 |
| Levin, J | 1 |
| Markham, M | 1 |
| Strain, GW | 1 |
| Fukushima, DK | 1 |
| MacFarlane, IA | 1 |
| Robinson, EL | 1 |
| Bush, H | 1 |
| Durning, P | 1 |
| Howat, JM | 1 |
| Beardwell, CG | 1 |
| Shalet, SM | 1 |
| Mi, YY | 1 |
| Zhou, MZ | 1 |
| Xiu, X | 1 |
| Dryzhak, VI | 1 |
| Quirin-Stricker, C | 1 |
| Nappey, V | 1 |
| Simoni, P | 1 |
| Toussaint, JL | 1 |
| Schmitt, M | 1 |
| Zhang, X | 1 |
| Jeyakumar, M | 1 |
| Bagchi, MK | 1 |
| Strain, JJ | 1 |
| Bokje, E | 1 |
| van't Veer, P | 1 |
| Coulter, J | 1 |
| Stewart, C | 1 |
| Logan, H | 1 |
| Odling-Smee, W | 1 |
| Spence, RA | 1 |
| Steele, K | 1 |
| Anker, GB | 1 |
| Lønning, PE | 1 |
| Aakvaag, A | 1 |
| Lien, EA | 1 |
| González-Sancho, JM | 1 |
| Alvarez-Dolado, M | 1 |
| Caelles, C | 1 |
| Muñoz, A | 1 |
| Dinda, S | 1 |
| Sanchez, A | 1 |
| Moudgil, V | 1 |
| Beex, LV | 1 |
| Ross, A | 2 |
| Smals, AG | 1 |
| Kloppenborg, PW | 1 |
| Puga, FJ | 1 |
| Welch, JS | 1 |
| Bisel, HF | 1 |
| Aldinger, KA | 1 |
| Schultz, PN | 1 |
| Blumenschein, GR | 1 |
| Samaan, NA | 1 |
| Gress, RE | 1 |
| Piantadosi, CA | 1 |
| Skubitz, KM | 1 |
| Hsu, TH | 1 |
| Burke, RE | 1 |
| McGuire, WL | 1 |
| Allegra, JC | 1 |
| Lippman, ME | 1 |
| Adami, HO | 3 |
| Hansen, J | 1 |
| Rimsten, A | 2 |
| Wide, L | 3 |
| Saito, S | 1 |
| Sakurada, T | 1 |
| Yoshida, K | 1 |
| Johansson, H | 1 |
| Thorén, L | 2 |
| Akerström, G | 1 |
| Beex, L | 1 |
| Smals, A | 1 |
| Kloppenborg, P | 1 |
| Vegelius, J | 1 |
| Haskell, CM | 1 |
| Sparks, FC | 1 |
| Graze, PR | 1 |
| Korenman, SG | 1 |
| Zhou-Li, F | 1 |
| Albaladejo, V | 1 |
| Joly-Pharaboz, MO | 1 |
| Nicolas, B | 1 |
| Andre, J | 1 |
| Bracke, ME | 1 |
| Van Larebeke, NA | 1 |
| Vyncke, BM | 1 |
| Mareel, MM | 1 |
| Dowsett, M | 1 |
| Mehta, A | 1 |
| Cantwell, BM | 1 |
| Harris, AL | 1 |
| Mercier-Bodard, C | 2 |
| Nivet, V | 1 |
| Baulieu, EE | 2 |
| Fernandez-Pol, JA | 3 |
| Raja, RH | 1 |
| Paterson, AJ | 1 |
| Shin, TH | 1 |
| Kudlow, JE | 1 |
| Barkhem, T | 1 |
| Carlsson, B | 1 |
| Simons, J | 1 |
| Möller, B | 1 |
| Berkenstam, A | 1 |
| Gustafsson, JA | 1 |
| Nilsson, S | 1 |
| Ramaker, J | 1 |
| Wood, WG | 1 |
| Baville, F | 1 |
| Bideux, G | 1 |
| Binart, N | 1 |
| Chambraud, B | 1 |
| Hamilton, PD | 2 |
| Klos, DJ | 2 |
| Takatani, O | 1 |
| Okumoto, T | 1 |
| Kosano, H | 1 |
| Nishida, M | 1 |
| Hiraide, H | 1 |
| Tamakuma, S | 1 |
| de Launoit, Y | 1 |
| Kiss, R | 1 |
| Mira-y-Lopez, R | 1 |
| Ossowski, L | 1 |
| Titov, VK | 1 |
| Kaplan, MA | 1 |
| Sloventator, VIu | 1 |
| Shakhtarin, VV | 1 |
| Khmelevskiĭ, IaM | 1 |
| Lemaire, M | 1 |
| Baugnet-Mahieu, L | 1 |
| Gordon, D | 1 |
| Beastall, GH | 1 |
| McArdle, CS | 1 |
| Thomson, JA | 1 |
| Adamopoulos, DA | 1 |
| Vassilaros, S | 1 |
| Kapolla, N | 1 |
| Papadiamantis, J | 1 |
| Georgiakodis, F | 1 |
| Michalakis, A | 1 |
| Enriori, CL | 1 |
| Orsini, W | 1 |
| del Carmen Cremona, M | 1 |
| Etkin, AE | 1 |
| Cardillo, LR | 1 |
| Reforzo-Membrives, J | 1 |
| Bruning, P | 1 |
| Bonfrèr, J | 1 |
| De Jong-Bakker, M | 1 |
| Nooyen, W | 1 |
| Burgers, M | 1 |
| Eckerström, S | 1 |
| Cappelaere, P | 1 |
| Williams, DC | 1 |
| Goldenberg, IS | 1 |
| McMahan, CA | 1 |
| Escher, GC | 1 |
| Volk, H | 1 |
| Ansfield, FJ | 1 |
| Olson, KB | 1 |
| Laakso, L | 1 |
| Nikkari, T | 1 |
| Grönroos, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Selenoproteins as Prognostic Markers and Therapeutic Targets in Breast Cancer.[NCT05817227] | 300 participants (Anticipated) | Observational | 2022-05-19 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 reviews available for triiodothyronine and Breast Cancer
| Article | Year |
|---|---|
Free triiodothyronine and free thyroxine hormone levels in relation to breast cancer risk: a meta-analysis.
Topics: Breast Neoplasms; Female; Humans; Thyroid Hormones; Thyrotropin; Thyroxine; Triiodothyronine | 2022 |
Thyroid Hormone in the Clinic and Breast Cancer.
Topics: Animals; Breast Neoplasms; Carcinogenesis; Hormone Replacement Therapy; Humans; Hypothyroidism; Thyr | 2018 |
Relationship between breast cancer and levels of serum thyroid hormones and antibodies: a meta-analysis.
Topics: Autoantibodies; Breast; Breast Neoplasms; Female; Humans; Iodide Peroxidase; Thyroglobulin; Thyroid | 2014 |
Modulation of EGF receptor protooncogene expression by growth factors and hormones in human breast carcinoma cells.
Topics: Biomarkers, Tumor; Breast Neoplasms; Cell Division; Cholecalciferol; Epidermal Growth Factor; ErbB R | 1991 |
[Hormone therapy in geriatrics].
Topics: Adrenocorticotropic Hormone; Aged; Androgens; Arteriosclerosis; Breast Neoplasms; Coronary Disease; | 1969 |
Steroid hormones and breast cancer.
Topics: Adrenal Cortex; Adrenal Glands; Adrenalectomy; Adrenocorticotropic Hormone; Age Factors; Binding Sit | 1974 |
1 trial available for triiodothyronine and Breast Cancer
| Article | Year |
|---|---|
Treatment of breast cancer with oral four-drug chemotherapy.
Topics: Administration, Oral; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Cyclophosph | 1980 |
99 other studies available for triiodothyronine and Breast Cancer
| Article | Year |
|---|---|
Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.
Topics: Amides; Breast Neoplasms; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Humans; Neopla | 2013 |
Low thyroid hormone receptor alpha-2 (THRα-2) tumor expression is associated with unfavorable tumor characteristics and high breast cancer mortality.
Topics: Breast; Breast Neoplasms; Female; Humans; Prognosis; Proportional Hazards Models; Thyroid Hormone Re | 2021 |
Thyroid Hormones and Morphological Features of Primary Breast Cancer.
Topics: Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; Carcinoma in Situ; Cell Proliferation; Female; Hum | 2022 |
Liothyronine Use in Hypothyroidism and its Effects on Cancer and Mortality.
Topics: Adult; Breast Neoplasms; Cause of Death; Drug Therapy, Combination; Female; Humans; Hypothyroidism; | 2021 |
Thyroid Hormones, Silencing Mediator for Retinoid and Thyroid Receptors and Prognosis in Primary Breast Cancer.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; Disease-Free Survival; Female; | 2020 |
Clinical Features of Nivolumab-Induced Thyroiditis: A Case Series Study.
Topics: Aged; Antibodies, Monoclonal; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Lung Neoplasm | 2017 |
Thyroid hormones and breast cancer association according to menopausal status and body mass index.
Topics: Adult; Body Mass Index; Breast Neoplasms; Case-Control Studies; Female; Humans; Incidence; Mexico; M | 2018 |
Triiodothyronine Promotes Cell Proliferation of Breast Cancer via Modulating miR-204/Amphiregulin.
Topics: Amphiregulin; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Gene Expression Regula | 2019 |
Serum concentration of thyroid hormones in abnormal and euthyroid ranges and breast cancer risk: A cohort study.
Topics: Adult; Breast; Breast Neoplasms; Cohort Studies; Female; Humans; Metabolic Syndrome; Middle Aged; Pr | 2019 |
Remission of autoimmune hyperthyroidism after chemotherapy for cancer.
Topics: Adult; Antithyroid Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Comorbidity; Female; Graves | 2014 |
Status of oral ulcerative mucositis and biomarkers to monitor posttraumatic stress disorder effects in breast cancer patients.
Topics: Adult; Aged; Biomarkers, Tumor; Blood Pressure; Breast Neoplasms; C-Reactive Protein; Female; Humans | 2013 |
Implication from thyroid function decreasing during chemotherapy in breast cancer patients: chemosensitization role of triiodothyronine.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Euthyroid Sick | 2013 |
Estrogen-responsive genes overlap with triiodothyronine-responsive genes in a breast carcinoma cell line.
Topics: Breast Neoplasms; Carcinoma; Estrogens; Female; Gene Expression Regulation, Neoplastic; Humans; MCF- | 2014 |
T3 levels in relation to prognostic factors in breast cancer: a population-based prospective cohort study.
Topics: Breast Neoplasms; Female; Humans; Lymphatic Metastasis; Middle Aged; Postmenopause; Prospective Stud | 2014 |
Thyroid Hormone Receptors Predict Prognosis in BRCA1 Associated Breast Cancer in Opposing Ways.
Topics: Adult; BRCA1 Protein; Breast Neoplasms; Cell Line, Tumor; Cohort Studies; Female; Humans; Immunohist | 2015 |
Prospectively measured thyroid hormones and thyroid peroxidase antibodies in relation to risk of different breast cancer subgroups: a Malmö Diet and Cancer Study.
Topics: Aged; Antibodies; Breast; Breast Neoplasms; Cyclin D1; Female; Humans; Iodide Peroxidase; Ki-67 Anti | 2015 |
Alteration of Thyroid Function in Indian HER 2-Negative Breast Cancer Patients Undergoing Chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Agents; Breast Neoplasms; Female; Humans; India; Middle Aged; Rece | 2015 |
Thyroid function and survival following breast cancer.
Topics: Aged; Antibodies; Breast Neoplasms; Female; Humans; Iodide Peroxidase; Middle Aged; Prospective Stud | 2016 |
Thyroid Hormone Controls Breast Cancer Cell Movement via Integrin αV/β3/SRC/FAK/PI3-Kinases.
Topics: Actin Cytoskeleton; Breast Neoplasms; Cell Adhesion; Cell Line, Tumor; Cell Movement; Female; Focal | 2017 |
Tamoxifen inhibits transforming growth factor-alpha gene expression in human breast carcinoma samples treated with triiodothyronine.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma; Cell Culture Techniques; Down-Regulatio | 2008 |
Influence of estradiol and triiodothyronine on breast cancer cell lines proliferation and expression of estrogen and thyroid hormone receptors.
Topics: Analysis of Variance; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Clone Cells; Estradiol | 2009 |
Determination and characterization of hydroxylated polychlorinated biphenyls (OH-PCBs) in serum and adipose tissue of Japanese women diagnosed with breast cancer.
Topics: Adipose Tissue; Breast Neoplasms; Female; Humans; Hydroxylation; Japan; Polychlorinated Biphenyls; T | 2010 |
Prospectively measured triiodothyronine levels are positively associated with breast cancer risk in postmenopausal women.
Topics: Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Cohort Studies; Female; Follow-Up Studies | 2010 |
Thyroid hormone differentially modulates Warburg phenotype in breast cancer cells.
Topics: Breast Neoplasms; Cell Line, Tumor; Female; Glucose Transporter Type 1; Glycolysis; Humans; Mitochon | 2011 |
Prospectively measured thyroid hormones and thyroid peroxidase antibodies in relation to breast cancer risk.
Topics: Autoantibodies; Breast Neoplasms; Cell Proliferation; Female; Humans; Iodide Peroxidase; Middle Aged | 2012 |
Triiodothyronine levels in relation to mortality from breast cancer and all causes: a population-based prospective cohort study.
Topics: Aged; Aged, 80 and over; Breast Neoplasms; Cohort Studies; Female; Follow-Up Studies; Humans; Middle | 2013 |
5'Deiodinase in two breast cancer cell lines: effect of triiodothyronine, isoproterenol and retinoids.
Topics: Adrenergic beta-Agonists; Breast Neoplasms; Cell Differentiation; DNA Primers; Female; Humans; Iodid | 2003 |
Labeled iodinated compounds in tumors and tissues of C3H mice after the injection of I 131-labeled triiodothyronine.
Topics: Animals; Breast Neoplasms; Humans; Iodine; Iodine Radioisotopes; Mice; Mice, Inbred C3H; Neoplasms; | 1960 |
The concentration of radioactive triiodothyronine in mammary tumors and tissues of C3H mice.
Topics: Animals; Breast Neoplasms; Humans; Iodine; Iodine Radioisotopes; Mammary Neoplasms, Animal; Mice; Mi | 1960 |
Response of mouse breast tumors to L-triiodohyronine and irradiation.
Topics: Animals; Brain Neoplasms; Breast Neoplasms; Fibroadenoma; Humans; Mice; Neoplasms; Radiation Effects | 1960 |
Calcium and phosphate metabolism in disseminated breast cancer: effects of site, progression or regression, and hormonal treatment.
Topics: Androgens; Breast; Breast Neoplasms; Calcium; Calcium, Dietary; Humans; Neoplasms; Phosphates; Predn | 1962 |
A clinical trial of tri-iodothyronine as a hormone potentiator in advanced breast cancer.
Topics: Breast; Breast Neoplasms; Estrogens; Humans; Triiodothyronine | 1962 |
Secondary hormonal therapy of disseminated breast cancer. Comparison of hypophysectomy, replacement therapy, estrogens, and androgens.
Topics: Anatomy; Androgens; Antineoplastic Agents; Biological Therapy; Breast Neoplasms; Estrogens; Fluoxyme | 1963 |
[THE EFFECT OF TRIIODOTHYRONINE ON STEROID EXCRETION].
Topics: Androgens; Androsterone; Breast Diseases; Breast Neoplasms; Estrogens; Humans; Steroids; Triiodothyr | 1963 |
CALCIUM AND PHOSPHATE METABOLISM IN PATIENTS WITH DISSEMINATED BREAST CANCER: EFFECT OF ANDROGENS AND OF PREDNISONE.
Topics: Androgens; Blood Chemical Analysis; Bone and Bones; Breast; Breast Neoplasms; Calcium; Calcium, Diet | 1963 |
GLOMERULAR FILTRATION IN DISSEMINATED BREAST CANCER.
Topics: Androgens; Breast Neoplasms; Creatine; Creatinine; Estrogens; Humans; Hydrocortisone; Hypophysectomy | 1964 |
EFFECT OF THYROID HORMONE ON HUMAN PITUITARY THYROID-STIMULATING HORMONE CONTENT.
Topics: Aged; Breast Neoplasms; Humans; Hypophysectomy; Physiology; Pituitary Diseases; Pituitary Gland; Thy | 1964 |
DIFFERENCES OF STEROID METABOLISM IN BREAST CANCER AFTER HORMONE STIMULATION.
Topics: 17-Ketosteroids; Adrenal Cortex Hormones; Androgens; Androsterone; Breast Diseases; Breast Neoplasms | 1964 |
[THYROID FUNCTION IN PATIENTS WITH CANCER OF THE BREAST].
Topics: Breast; Breast Neoplasms; Humans; Metabolism; Neoplasms; Pathology; Thyroid Function Tests; Thyroid | 1964 |
Three novel hormone-responsive cell lines derived from primary human breast carcinomas: functional characterization.
Topics: Adult; Aged; Anti-Inflammatory Agents; Breast Neoplasms; Cell Culture Techniques; Cell Division; Cel | 2004 |
The Na+/I- symporter mediates iodide uptake in breast cancer metastases and can be selectively down-regulated in the thyroid.
Topics: Breast Neoplasms; Down-Regulation; Female; Humans; Immunohistochemistry; Iodides; Neoplasm Metastasi | 2004 |
Human breast cancer tissue expresses high level of type 1 5'-deiodinase.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Cell Differentiation; Enzyme Activation; Female; G | 2007 |
Effects of thyroid hormones on human breast cancer cell proliferation.
Topics: Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Estradiol; Estro | 2008 |
Thyroid hormone receptors in human breast cancer.
Topics: Adult; Aged; Animals; Biopsy; Breast Neoplasms; Cell Nucleus; Female; Humans; Liver; Male; Middle Ag | 1981 |
Hormone supplemented media for cloning human breast cancer: increased colony formation without alteration of chemosensitivity.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line; Cell Survival; Culture Media; Dexamethasone; Din | 1983 |
[Thyroid and hypophyseal function during radiation therapy of breast cancer].
Topics: Adult; Breast Neoplasms; Female; Growth Hormone; Humans; Insulin; Menopause; Middle Aged; Pituitary | 1984 |
[Indices of thyroid activity in patients with breast cancer].
Topics: Adult; Breast Neoplasms; Female; Humans; Middle Aged; Thyroid Function Tests; Thyroid Gland; Thyrotr | 1984 |
Thyroid function in early breast cancer.
Topics: Adult; Aged; Androsterone; Breast Neoplasms; Etiocholanolone; Female; Humans; Mastectomy; Middle Age | 1983 |
Thyroid hormone-inducible mitochondrial alpha-glycerophosphate dehydrogenase in the MCF-7 human breast cancer cell line.
Topics: Breast Neoplasms; Cell Line; Dactinomycin; Enzyme Induction; Glycerolphosphate Dehydrogenase; Humans | 1983 |
Pituitary-thyroid function in patients with breast cancer.
Topics: Breast Neoplasms; Female; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Middle Aged; Pituitary | 1980 |
Plasma thyronine levels in carcinoma of the breast and colon.
Topics: Adult; Breast Neoplasms; Carcinoma; Colonic Neoplasms; Female; Humans; Liver Neoplasms; Middle Aged; | 1981 |
Plasma levels of thyroxine and triiodothyronine in women with breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Middle Aged; Neoplasms; Thyroxine; Triiodothyronine | 1981 |
Thyroid function in patients with benign and malignant breast disease.
Topics: Adolescent; Adult; Aged; Breast Diseases; Breast Neoplasms; Female; Humans; Middle Aged; Thyroid Fun | 1980 |
[Study of relationship between TCM syndrome-types of malignant tumours and thyroid functional test].
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Diagnosis, Differential; Digestive System Neoplasm | 1995 |
[Thyroid function in breast cancer patients].
Topics: Adult; Breast Neoplasms; Female; Humans; Menopause; Middle Aged; Radioimmunoassay; Thyroid Gland; Th | 1993 |
Trans-activation by thyroid hormone receptors of the 5' flanking region of the human ChAT gene.
Topics: Amino Acid Sequence; Animals; Base Sequence; Breast Neoplasms; Cells, Cultured; Chlorocebus aethiops | 1994 |
Ligand-dependent cross-talk between steroid and thyroid hormone receptors. Evidence for common transcriptional coactivator(s).
Topics: Animals; beta-Galactosidase; Breast Neoplasms; Cell Line; Cell Nucleus; Cell-Free System; Chloramphe | 1996 |
Thyroid hormones and selenium status in breast cancer.
Topics: Aged; Breast Neoplasms; Case-Control Studies; Female; Humans; Iodide Peroxidase; Middle Aged; Nails; | 1997 |
Triiodothyronine mimics the effects of estrogen in breast cancer cell lines.
Topics: Breast Neoplasms; Carcinoma; Cell Division; Estradiol; Estrogen Antagonists; Gene Expression Regulat | 1996 |
Thyroid function in postmenopausal breast cancer patients treated with tamoxifen.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Breast Neoplasms; Female; Humans; Middle Aged; Postme | 1998 |
Inhibition of tenascin-C expression in mammary epithelial cells by thyroid hormone.
Topics: Animals; Breast; Breast Neoplasms; Cell Line; Dexamethasone; Epithelial Cells; Female; Humans; Mamma | 1999 |
Estrogen-like effects of thyroid hormone on the regulation of tumor suppressor proteins, p53 and retinoblastoma, in breast cancer cells.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Division; Dose-Response Relationship, Drug; Estrad | 2002 |
Letter: 5-fluorouracil and the thyroid.
Topics: Breast Neoplasms; Female; Fluorouracil; Humans; Thyroid Gland; Thyrotropin; Thyroxine; Triiodothyron | 1976 |
Therapeutic oophorectomy in disseminated carcinoma of the breast.
Topics: Adult; Androgens; Breast Neoplasms; Castration; Female; Glucocorticoids; Humans; Hypophysectomy; Mid | 1976 |
Thyroid-stimulating hormone and prolactin levels in breast cancer.
Topics: Adult; Breast Neoplasms; Female; Humans; Hypothalamo-Hypophyseal System; Middle Aged; Prolactin; Thy | 1978 |
Breast carcinoma, thyroid carcinoma, and T3 thyrotoxicosis in a male cretin.
Topics: Adenocarcinoma; Aged; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Congenital Hypothyr | 1977 |
Nuclear thyroid hormone receptors in a human breast cancer cell line.
Topics: Binding, Competitive; Breast Neoplasms; Cell Division; Cell Line; Cell Nucleus; Humans; Kinetics; Ne | 1978 |
Growth of a human breast cancer cell line in serum-free hormone-supplemented medium.
Topics: Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Cell Division; Cell Line; Cell Survival; | 1978 |
Plasma triiodothyronine concentrations in breast cancer.
Topics: Adult; Age Factors; Aged; Breast Neoplasms; Colonic Neoplasms; Female; Humans; Middle Aged; Thyroid | 1979 |
Thyroid function in breast cancer patients before and up to two years after mastectomy.
Topics: Adult; Aged; Breast Neoplasms; Female; Follow-Up Studies; Humans; Mastectomy; Middle Aged; Thyroid F | 1979 |
The thyroid reserve in patients with breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Humans; Hypothyroidism; Middle Aged; Thyroiditis, Autoimmune; Thyroxi | 1977 |
Serum levels of TSH, T3, rT3, T4 and T3-resin uptake in surgical trauma.
Topics: Adult; Aged; Breast Neoplasms; Cholecystectomy; Female; Humans; Mastectomy; Middle Aged; Resins, Pla | 1978 |
5-fluorouracil-induced increase of total serum thyroxine and triiodothyronine.
Topics: Aged; Breast Neoplasms; Female; Fluorouracil; Humans; Middle Aged; Thyrotropin; Thyroxine; Triiodoth | 1977 |
Thyroid disease and function in breast cancer patients and non-hospitalized controls evaluated by determination of TSH, T3, rT3 and T4 levels in serum.
Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Middle Aged; Thyroid Diseases; Thyroid Gland; Thyrotr | 1978 |
Systemic therapy for metastatic breast cancer.
Topics: BCG Vaccine; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Estrogens; Female; Fluor | 1977 |
Antiestrogens prevent the stimulatory effects of L-triiodothyronine on cell proliferation.
Topics: Breast Neoplasms; Cell Division; DNA, Neoplasm; Estradiol; Estrogen Antagonists; Female; Humans; Ins | 1992 |
Retinoic acid modulates both invasion and plasma membrane ruffling of MCF-7 human mammary carcinoma cells in vitro.
Topics: Animals; Breast Neoplasms; Cell Aggregation; Cell Division; Cell Line; Cell Membrane; Chick Embryo; | 1991 |
Low-dose aminoglutethimide in postmenopausal breast cancer: effects on adrenal and thyroid hormone secretion.
Topics: 17-alpha-Hydroxyprogesterone; Adrenocorticotropic Hormone; Aminoglutethimide; Androstenedione; Breas | 1991 |
Effects of hormones on SBP mRNA levels in human cancer cells.
Topics: Blotting, Northern; Breast Neoplasms; Carcinoma; Carcinoma, Hepatocellular; Cycloheximide; Endometri | 1991 |
Transcriptional regulation of the human transforming growth factor-alpha gene.
Topics: Base Sequence; Breast Neoplasms; Dexamethasone; Dose-Response Relationship, Drug; Epidermal Growth F | 1991 |
High level expression of functional full length human thyroid hormone receptor beta 1 in insect cells using a recombinant baculovirus.
Topics: Animals; Baculoviridae; Base Sequence; Blotting, Western; Breast Neoplasms; Cell Line; Cell Nucleus; | 1991 |
Transthyretin--an explanation of "anomalous" serum thyroid hormone values in severe illness?
Topics: Adult; Aged; Breast Neoplasms; Female; Gastrointestinal Neoplasms; Humans; Hyperthyroidism; Hypothyr | 1990 |
Regulation of SBP synthesis in human cancer cell lines by steroid and thyroid hormones.
Topics: Blotting, Northern; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Line; Estradiol; Female; Gene | 1989 |
Transcriptional regulation of proto-oncogene expression by epidermal growth factor, transforming growth factor beta 1, and triiodothyronine in MDA-468 cells.
Topics: Breast Neoplasms; Drug Synergism; Epidermal Growth Factor; ErbB Receptors; Gene Expression Regulatio | 1989 |
Modulation of transforming growth factor alpha-dependent expression of epidermal growth factor receptor gene by transforming growth factor beta, triiodothyronine, and retinoic acid.
Topics: Breast Neoplasms; Dose-Response Relationship, Drug; Drug Interactions; Epidermal Growth Factor; ErbB | 1989 |
Relationship between the levels of serum thyroid hormones or estrogen status and the risk of breast cancer genesis in Japanese women.
Topics: Adult; Breast Neoplasms; Estradiol; Female; Humans; Japan; Menopause; Middle Aged; Random Allocation | 1989 |
Influence of L-thyroxine, L-triiodothyronine, thyroid stimulating hormone, or estradiol on the cell kinetics of cultured mammary cancer cells.
Topics: Animals; Breast Neoplasms; Cell Cycle; Drug Interactions; Estradiol; Humans; Interphase; Kinetics; M | 1989 |
Hormonal modulation of plasminogen activator: an approach to prediction of human breast tumor responsiveness.
Topics: Adenylyl Cyclases; Breast Neoplasms; Cell Survival; Cycloheximide; Estradiol; Humans; Hydrocortisone | 1987 |
[Radionuclide evaluation of postoperative catabolism in breast cancer].
Topics: Adult; Albumins; Body Composition; Breast Neoplasms; C-Peptide; Female; Humans; Hydrocortisone; Insu | 1988 |
Thyroid function in women with breast cancer.
Topics: Adult; Aged; Breast Diseases; Breast Neoplasms; Female; Humans; Middle Aged; Neoplasms; Thyroid Glan | 1986 |
The effect of tamoxifen therapy on thyroid function tests.
Topics: Breast Neoplasms; Female; Humans; Menopause; Middle Aged; Tamoxifen; Thyroid Function Tests; Thyroid | 1986 |
Thyroid disease in patients with benign and malignant mastopathy.
Topics: Adult; Aged; Breast Diseases; Breast Neoplasms; Female; Fibrocystic Breast Disease; Humans; Middle A | 1986 |
Decrease of circulating level of SHBG in postmenopausal obese women as a risk factor in breast cancer: reversible effect of weight loss.
Topics: Aged; Androstenedione; Body Weight; Breast Neoplasms; Estradiol; Estrone; Female; Humans; Hydrocorti | 1986 |
Primary hypothyroidism in breast cancer patients with irradiated supraclavicular lymph nodes.
Topics: Aged; Autoantibodies; Breast Neoplasms; Female; Humans; Hypothyroidism; Lymph Nodes; Lymphatic Metas | 1985 |
Current concepts in the treatment of advanced breast cancer.
Topics: Adrenalectomy; Adult; Androgens; Breast Neoplasms; Castration; Estrogens; Female; Fluorouracil; Huma | 1972 |
[Hormonotherapy of so-called solid tumors].
Topics: Adrenal Cortex Hormones; Adult; Androgens; Bone Neoplasms; Breast Neoplasms; Castration; Diethylstil | 1972 |
Secondary chemotherapy of advanced breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Chlorambucil; Female; Humans; Hydrocortisone; Middle Aged; Neoplasm M | 1973 |
Triiodothyronine uptake test in gynecologic radiation therapy.
Topics: Adult; Aged; Breast Neoplasms; Cobalt Isotopes; Female; Genital Neoplasms, Female; Humans; Middle Ag | 1969 |
[Effect of L-triiodothyronine on the elimination of steroids in advanced breast cancer].
Topics: Adrenal Cortex Hormones; Adult; Androsterone; Breast Neoplasms; Female; Humans; Hydrocortisone; Hype | 1964 |